This study is looking at how continuous glucose monitoring (CGM) can help people with severe obesity who are having metabolic bariatric surgery (weight loss surgery). Researchers want to see if using the Abbott Freestyle Libre CGM system, which tracks your blood sugar levels throughout the day, is more helpful than traditional self-monitoring of blood glucose. The study will enroll 20 participants between 20 and 60 years old who have a BMI of 35 or higher. Half will use the CGM, and the other half will use traditional blood sugar monitoring. The main goal is to see the differences in blood sugar variability (how much your blood sugar goes up and down) after 9 months.

Study design

This is an interventional study that will randomize 20 participants into two groups: one using the Abbott Freestyle Libre CGM and one using self-monitoring of blood glucose.

What's involved

Participants assigned to the CGM group will receive the Libre 2+ system and comprehensive training from a healthcare professional.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint is evaluated at 9 months, suggesting follow-up for at least that duration.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.